List of Immunovia patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11320436 Methods, arrays and uses thereof	Patent 11320436 was granted and assigned to Immunovia on May, 2022 by the United States Patent and Trademark Office.	Immunovia	Immunovia	United States Patent and Trademark Office	11320436	May 3, 2022
‌ US Patent 11525832 Protein signature/markers for the detection of adenocarcinoma	Patent 11525832 was granted and assigned to Immunovia on December, 2022 by the United States Patent and Trademark Office.	Immunovia	Immunovia	United States Patent and Trademark Office	11525832	December 13, 2022
‌ US Patent 10048265 Methods and arrays for use in the same	Patent 10048265 was granted and assigned to Immunovia on August, 2018 by the United States Patent and Trademark Office.	Immunovia	Immunovia	United States Patent and Trademark Office	10048265	August 14, 2018
‌ US Patent 10564163 Method, array and use thereof	Patent 10564163 was granted and assigned to Immunovia on February, 2020 by the United States Patent and Trademark Office.	Immunovia	Immunovia	United States Patent and Trademark Office	10564163	February 18, 2020
‌ US Patent 9863960 Method, array and use for determining the presence of pancreatic cancer	Patent 9863960 was granted and assigned to Immunovia on January, 2018 by the United States Patent and Trademark Office.		Immunovia	United States Patent and Trademark Office	9863960	January 9, 2018
‌ US Patent 10859572 Biomarker signatures and uses thereof		Immunovia	Immunovia	United States Patent and Trademark Office	10859572	December 8, 2020
‌ US Patent 9388469 Sox11 expression in malignant lymphomas	Patent 9388469 was granted and assigned to Immunovia on July, 2016 by the United States Patent and Trademark Office.		Immunovia	United States Patent and Trademark Office	9388469	July 12, 2016